Skip to main content

Table 2 Presentation characteristics of patients with first ST-segment elevation myocardial infarction by number of cardiovascular risk factors

From: Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry

Variables

Total (N = 16228)

No SMuRF (N = 1918)

1–2 SMuRFs (N = 11503)

3–4 SMuRFs (N = 2807)

P value

Presentation characteristics

 Emergency medical system

1736 (10.7)

186 (9.7)

1204 (10.5)

346 (12.4)

0.0009

 Onset-to-arrival time

    

<0.0001

  <3 h

3844 (23.9)

392 (20.7)

2681 (23.5)

771 (27.6)

 

  3–12 h

6974 (43.3)

811 (42.9)

4965 (43.5)

1198 (42.9)

 

  12–24 h

1665 (10.3)

197 (10.4)

1190 (10.4)

278 (10.0)

 

  1–7 d

3619 (22.5)

491 (26.0)

2584 (22.6)

544 (19.5)

 

 Time for symptoms to first medical contact, minute

328 (139–1124)

370 (165–1441)

330 (140–1115)

300 (120–1005)

0.0001

 GRACE risk score

148.4±35.4

156.1±35.7

148.5±34.9

143.1±36.5

<0.0001

 Systolic blood pressure, mmHg

127.3±24.9

120.5±22.1

127.1±24.5

133.1±27.0

<0.0001

 Heart rate, beats/min

77.4±18.1

76.8±18.0

77.2±18.0

78.9±18.6

<0.0001

 Cardiac arrest at presentation

207 (1.3)

24 (1.3)

144 (1.3)

39 (1.4)

0.84

 Killip class

    

0.21

  I

12466 (77.2)

1484 (77.7)

8846 (77.2)

2136 (76.4)

 

  II

2510 (15.5)

276 (14.5)

1805 (15.8)

429 (15.3)

 

  III

566 (3.5)

68 (3.6)

385 (3.4)

113 (4.0)

 

  IV

615 (3.8)

81 (4.2)

416 (3.6)

118 (4.2)

 

 LVEF

    

0.06

  Normal, >50%

8633 (68.5)

899 (66.2)

6172 (68.6)

1562 (69.1)

 

  Slightly, 40–49%

3050 (24.2)

340 (25.0)

2193 (24.4)

517 (22.9)

 

  Moderately, 30–39%

797 (6.3)

99 (7.3)

546 (6.1)

152 (6.7)

 

  Severely, <30%

132 (1.0)

21 (1.5)

83 (0.9)

28 (1.2)

 

 Anterior myocardial infarction

9091 (56.2)

1121 (58.6)

6431 (56.1)

1539 (55.0)

0.048

 Three-vessel coronary artery diseasea

3762 (36.4)

300 (29.2)

2624 (35.9)

838 (41.9)

<0.0001

Laboratory variables

 Creatinine, mmol/L

74.0 (61.7–90.0)

71.0 (59.0–87.0)

74.0 (62.0–90.0)

75.5 (62.0–91.0)

<0.0001

 Glucose, mmol/L

7.0 (5.7–9.1)

6.4 (5.4–7.6)

6.8 (5.6–8.7)

9.2 (6.8–12.8)

<0.0001

 Glycated hemoglobin A1c, %

6.0 (5.5–7.0)

5.6 (5.3–6.0)

5.9 (5.5–6.5)

6.9 (6.0–8.3)

<0.0001

 Total cholesterol, mmol/L

4.5 (3.8–5.3)

4.1 (3.6–4.6)

4.5 (3.8–5.2)

5.3 (4.4–5.9)

<0.0001

 Triglycerides, mmol/L

1.4 (1.0–2.0)

1.1 (0.8–1.6)

1.4 (1.0–2.0)

1.7 (1.2–2.6)

<0.0001

 LDL cholesterol, mmol/L

2.8 (2.2–3.4)

2.4 (2.0–2.8)

2.7 (2.2–3.3)

3.4 (2.6–3.8)

<0.0001

 HDL cholesterol, mmol/L

1.1 (0.9–1.3)

1.1 (0.9–1.3)

1.1 (0.9–1.3)

1.1 (0.9–1.3)

0.16

  1. SMuRF Standard modifiable cardiovascular risk factor, LVEF Left ventricular ejection fraction
  2. aInformation on three-vessel coronary artery disease was only available for patients who conducted coronary angiography (n = 11045)